126 related articles for article (PubMed ID: 16584154)
1. Effect of pH on sublingual absorption of oxycodone hydrochloride.
Al-Ghananeem AM; Malkawi AH; Crooks PA
AAPS PharmSciTech; 2006 Mar; 7(1):E23. PubMed ID: 16584154
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH on sublingual absorption of oxycodone hydrochloride.
Al-Ghananeem AM; Malkawi AH; Crooks PA
AAPS PharmSciTech; 2006 Mar; 7(1):E163-E167. PubMed ID: 28290038
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children.
Kokki H; Rasanen I; Lasalmi M; Lehtola S; Ranta VP; Vanamo K; Ojanperä I
Clin Pharmacokinet; 2006; 45(7):745-54. PubMed ID: 16802855
[TBL] [Abstract][Full Text] [Related]
4. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
[TBL] [Abstract][Full Text] [Related]
5. Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness.
Al-Ghananeem AM; Malkawi AH; Crooks PA
Drug Dev Ind Pharm; 2007 May; 33(5):577-82. PubMed ID: 17520450
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
Parikh N; Goskonda V; Chavan A; Dillaha L
Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
9. Sublingual absorption of selected opioid analgesics.
Weinberg DS; Inturrisi CE; Reidenberg B; Moulin DE; Nip TJ; Wallenstein S; Houde RW; Foley KM
Clin Pharmacol Ther; 1988 Sep; 44(3):335-42. PubMed ID: 2458208
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
Kokki H; Rasanen I; Reinikainen M; Suhonen P; Vanamo K; Ojanperä I
Clin Pharmacokinet; 2004; 43(9):613-22. PubMed ID: 15217304
[TBL] [Abstract][Full Text] [Related]
11. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
Rawas-Qalaji MM; Simons FE; Simons KJ
J Allergy Clin Immunol; 2006 Feb; 117(2):398-403. PubMed ID: 16461140
[TBL] [Abstract][Full Text] [Related]
12. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
13. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
Rawas-Qalaji MM; Simons FE; Simons KJ
Biopharm Drug Dispos; 2006 Dec; 27(9):427-35. PubMed ID: 17009337
[TBL] [Abstract][Full Text] [Related]
16. Grapefruit juice enhances the exposure to oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
[TBL] [Abstract][Full Text] [Related]
17. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
Gu X; Simons KJ; Simons FE
Biopharm Drug Dispos; 2002 Jul; 23(5):213-6. PubMed ID: 12116053
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
20. The effect of hydroxypropyl-beta-cyclodextrin and sucrose on the sublingual absorption of midazolam in rabbits.
Kaartama R; Turunen E; Toljamo K; Kokki H; Lehtonen M; Ranta VP; Savolainen J; Järvinen K; Jarho P
Eur J Pharm Biopharm; 2012 May; 81(1):178-83. PubMed ID: 22321528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
